Skip to content

Effect of kushmanda ghrta pratimarsha nasya in Attention Deficit Hyperactivity disorder

Add on effect of Kusmanda Ghrta Pratimarsa nasya along with selected Ayurveda treatment modalities in improving reaction time in children with Attention Deficit Hyperactivity Disorder - A comparative clinical trial - NIL

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079108
Enrollment
20
Registered
2025-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F900- Attention-deficit hyperactivity disorder, predominantly inattentive type

Interventions

None listed

Sponsors

Subitha V
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants satisfying the DSM 5 Diagnostic criteria for ADHD with inattention14 2. Participants in the age group 5-12 years 3. No discrimination of sex, religion, caste and economic status 4. Participant’s (5 to 7 years) Parent’s informed consent will be taken. ? Participant’s (7 to 12 years) verbal assent and parent’s informed consent will be taken.

Exclusion criteria

Exclusion criteria: 1. Moderate and severe intellectual Disability 2. Pervasive developmental disorder 3. Epilepsy and other neurological disorder 4. Participants undergoing other psychopharmacological interventions

Design outcomes

Primary

MeasureTime frame
The reaction time will be assessed using Vernier chronoscope and Conner’s revised rating scale.Timepoint: Assessment will be done on 0th day, 31st day and 61st day

Secondary

MeasureTime frame
assess the add on effect of Pratimars’a nasya with Kusm ?n ?a Ghrta in ADHD with Conner’s revised rating scaleTimepoint: Assessment will be done on 0th day, 31st day and 61st day

Countries

India

Contacts

Public ContactDr Vinod R

V P S V Ayurveda college,Kottakkal

drvinodvarier@gmail.com09846302667

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026